Theravance Biopharma, Inc. (TBPH) Annual Margin Report - Discounting Cash Flows
TBPH
Theravance Biopharma, Inc.
TBPH (NASDAQ)

Annual Margin Analysis Report

Margins refer to the ratio between a financial report item and the revenue (Example: Net Income Margin = Net Income / Revenue).

This analysis provides a report of the company's key margins, which could be further used in a valuation model.

Interactive Assumptions

Historical Years

Historical Years

Number of historical years used to render the Chart and Tables.

Margin Analysis (% of Revenue)

Monetary values are in USD

amounts of USD except for #

Average LTM 2024 2023 2022 2021 2020
Revenue 60.93 65.27 64.38 57.42 51.35 55.31 71.86
Revenue Growth Rate -1.16% 1.38% 12.12% 11.84% -7.17% -23.03% -2.12%
Cost of Revenue 91.61 0 0 0 6.59 7.29 261
Gross Profit 15.13 65.27 64.38 57.42 44.76 48.02 -189.1
Gross Margin 35.13% 100% 100% 100% 87.17% 86.83% -263.2%
Operating Income -133.4 -50.18 -46.95 -56.03 -91.96 -257.8 -297.8
Operating Margin -217.8% -76.88% -72.92% -97.58% -179.1% -466.1% -414.4%
Net Income -123.4 -58.33 -56.42 -55.19 -92.82 -199.4 -278
Net Margin -200.2% -89.38% -87.63% -96.11% -180.8% -360.6% -386.9%

amounts of USD except for #

Average LTM 2024 2023 2022 2021 2020
Revenue 60.93 65.27 64.38 57.42 51.35 55.31 71.86
Cash From Operating Activities Margin -183.9% 49.84% -17.92% -47.01% -364.2% -375.8% -348.5%
Cash From Operating Activities -108.5 32.53 -11.54 -27 -187 -207.9 -250.4
Free Cash Flow Margin -187.6% 49.47% -18.43% -51.35% -365.3% -382% -357.7%
Free Cash Flow -110.8 32.28 -11.87 -29.48 -187.6 -211.3 -257
Depreciation and Amortization Margin 10.37% 5.34% 5.62% 7.41% 13.68% 17.55% 12.61%
Depreciation and Amortization 6.19 3.49 3.62 4.26 7.02 9.71 9.06
Capital Expenditure Margin -3.62% -0.369% -0.516% -4.33% -1.11% -6.16% -9.21%
Capital Expenditure -2.28 -0.241 -0.332 -2.49 -0.572 -3.41 -6.62
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us